Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows a new revision tag (v3.6.4). The revision history now lists v3.6.4 as the current version, replacing the previous v3.6.3.SummaryDifference0.1%

- Check20 days agoChange DetectedNew schedule milestones were added to the study record, including the latest update date and revised completion timelines that extend into 2027. Older milestone dates were removed, signaling an update to the study's expected timeline and status.SummaryDifference0.3%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3, indicating a newer revision of the study record page. This reflects internal maintenance and does not change the study data or primary content.SummaryDifference0.1%

- Check55 days agoChange DetectedIntroduces a recruitment notice and new navigation aids to help users understand and join the study; includes a minor formatting change to the Intervention header and a new revision tag (v3.6.0).SummaryDifference0.4%

- Check62 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a new build/version of the page.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision tag has been updated to v3.5.4, replacing v3.5.3, signaling a minor update to the page version.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.